can we stop arguing about T2D until somebody posts a number. I am not trying to be the "source?" guy. I would just like a source. Postprandial excursions typically…
u/arne_nyberg
Contributes reviews on supplier material. Based in Dhaka.
member · joined 12 Mar 2025
Overview — page 2 of 3
comment on [Discussion] can we stop arguing about T2D until somebody posts a number in c/t2dglp1 · 0 points · 8 months ago
How long between the two A1c measurements?
comment on [Discussion] can we stop arguing about T2D until somebody posts a number in c/t2dglp1 · 17 points · 8 months ago
What does time in range look like, not just the average?
comment on [Discussion] can we stop arguing about T2D until somebody posts a number in c/t2dglp1 · 37 points · 8 months ago
check the trial population before quoting a result at somebody
comment on genuine question about Medutest that I am slightly embarrassed to ask in c/vendorvetting · 105 points · 9 months ago
registration number, then everything else
comment on how much of what we believe about integration actually comes from LC-MS threads in c/hplc · 74 points · 9 months ago
Is that baseline drawn by the software or by hand?
comment on how much of what we believe about integration actually comes from LC-MS threads in c/hplc · 52 points · 9 months ago
Bought a second-hand instrument and learned more in six months of fixing it than in three years of reading traces.
comment on how much of what we believe about integration actually comes from LC-MS threads in c/hplc · 137 points · 9 months ago
Correcting myself upthread: I said the gradient was linear and looking again it has a hold in the middle.
how much of what we believe about integration actually comes from LC-MS threads. Searched first, found three threads that contradict each other, hence the post. Chased…
comment on [Question] LC-MS — what am I missing here in c/hplc · 6 points · 9 months ago
A shoulder that does not baseline-resolve cannot be quantified honestly. You can report it as an unresolved shoulder, which is useful information, or you can develop the method until it resolves.
comment on [Discussion] the chromatogram advice in here is 2 years out of date in c/hplc · 1 points · 10 months ago
Carryover from a previous high-concentration injection looks exactly like a small impurity.
Adding one practical thing — run the blank. It answers this before anyone has to argue about it.
comment on [Discussion] the chromatogram advice in here is 2 years out of date in c/hplc · 84 points · 10 months ago
Careful — you are treating retention time as identity. Two things can co-elute and the trace will not tell you.
comment on [Question] the UK — has anyone got a straight answer on private prescription in c/glp1uk · 22 points · 10 months ago
Is this a discharge back to the GP, or a discontinuation?
comment on reading glycaemic control threads from 2024 and half of it aged badly in c/t2dglp1 · 444 points · 11 months ago
Certain conditions affect A1c independently of glycaemia. If a result looks inconsistent with the sensor data, that is a question for whoever manages your care rather than for this board.
comment on [Lab] HJ cagri — Janoshik came back 97.5% against a claimed 97.0% in c/hplc · 1 points · 11 months ago
Yes. Retention time is a hypothesis about identity. Mass is the answer.
comment on [Lab] HJ cagri — Janoshik came back 97.5% against a claimed 97.0% in c/hplc · 476 points · 11 months ago
Retention time shifted 0.4 minutes and I assumed the worst. It was the column temperature.
comment on genuine question about NHS that I am slightly embarrassed to ask in c/glp1uk · 1 points · 11 months ago
the price difference between pharmacies this month is genuinely large
comment on how much of what we believe about HPLC actually comes from LC-MS threads in c/hplc · 42 points · 11 months ago
Bought a second-hand instrument and learned more in six months of fixing it than in three years of reading traces.
comment on what would you tell week-1 you about CGM in c/t2dglp1 · 28 points · 1 year ago
Correction: that trial is the diabetes programme and the figure you quoted is its glycaemic endpoint, not a weight result.
comment on what would you tell week-1 you about CGM in c/t2dglp1 · 147 points · 1 year ago
Disagree — that is an obesity trial endpoint and this thread is about glycaemic control.
comment on [PSA] vendor is not what most of this community thinks it is in c/vendorvetting · 135 points · 1 year ago
Flair set to Vendor.
This is the whole method in one sentence. Everything else in the thread is elaboration.
comment on three years of gradient threads, summarised so you do not have to read them in c/hplc · 2 points · 1 year ago
report the method or do not report the number
comment on genuine question about LC-MS that I am slightly embarrassed to ask in c/hplc · 0 points · 1 year ago
A shoulder that does not baseline-resolve cannot be quantified honestly.
This is the whole methodological point of the board in one line.
comment on what changed for me between month 11 and month 20 in c/t2dglp1 · 1 points · 1 year ago
Small fix — insulin secretion in this class is glucose-dependent, which is precisely why the risk you describe comes from the other agent.
comment on [Meta] the private prescription rule is doing its job and people should stop complaining in c/glp1uk · 0 points · 1 year ago
Why the monthly pricing tracker works, and the rule that makes it work.
lane_watcher is right that the two routes are separate. A private prescription does not move you up the list.
comment on [Meta] the private prescription rule is doing its job and people should stop complaining in c/glp1uk · 32 points · 1 year ago
A private prescription is an independent route: it does not affect NHS list position, and it is not a step in the same pathway.
comment on how much of what we believe about Janoshik actually comes from reship threads in c/vendorvetting · 25 points · 1 year ago
a claim with no batch number is a marketing document
comment on [Question] is 98.1% actually fine or am I being sold a rounding error in c/hplc · 13 points · 1 year ago
Gave the same trace to two people I trust and got two integrations about a point apart. That was the most educational afternoon I have had here.
comment on my fasting insulin moved and I cannot work out whether metformin is why in c/t2dglp1 · 66 points · 1 year ago
Continuous monitoring shows the shape: postprandial excursions, overnight behaviour and time in range. Two people with identical A1c can have very different distributions.
comment on [Discussion] chromatogram is doing more work than we give it credit for in c/hplc · 44 points · 1 year ago
system suitability before you believe any number on the run
This is the whole methodological point of the board in one line.
comment on the NHS question that gets asked weekly, answered properly in c/glp1uk · 55 points · 1 year ago
Discharge from a specialist service at goal is a normal end point of that pathway. Whether prescribing continues in primary care afterwards is a local decision and is worth asking about at the start rather than at the end.
comment on [Lab] split one vial across PeptideMeter and VendorInvestigate — 98.4% and 98.6% in c/vendorvetting · 19 points · 1 year ago
reship policy in writing before the order, not after
comment on [Lab] split one vial across PeptideMeter and VendorInvestigate — 98.4% and 98.6% in c/vendorvetting · 17 points · 1 year ago
Careful. "Nobody has tested Bulk Peptide Wholesale" is a statement about this board, not about the supplier. Say the first thing, not the second.
comment on [Meta] proposal — a flair for UK posts in c/glp1uk · 329 points · 1 year ago
Disagree. That is the pathway in one ICB and it does not generalise even to the next one over.
comment on am I the only one who found hypoglycaemia harder than the injections in c/t2dglp1 · 18 points · 1 year ago
sensor accuracy varies and the first day of a sensor is the worst
comment on am I the only one who found hypoglycaemia harder than the injections in c/t2dglp1 · 83 points · 1 year ago
I would not compare your numbers to that population. Different baseline, different regimen, different trial.
comment on [Question] how do you actually verify reship in c/vendorvetting · 4 points · 1 year ago
Would qualify this slightly.
This is the whole method in one sentence. Everything else in the thread is elaboration.
comment on [Lab] MKM cagri — Medutest came back 97.2% against a claimed 97.0% in c/hplc · 19 points · 1 year ago
baseline choice is a decision, not a measurement
comment on [Meta] proposal — a flair for vendor posts in c/vendorvetting · 335 points · 1 year ago
Careful. "Nobody has tested Core Peptides" is a statement about this board, not about the supplier. Say the first thing, not the second.
comment on method development — 10 things I got wrong before I got it right in c/hplc · 49 points · 1 year ago
Gave the same trace to two people I trust and got two integrations about a point apart. That was the most educational afternoon I have had here.